Annovis Bio, Inc.: Annovis Bio to Present at the H.C. Wainwright Global Life Sciences Conference
Berwyn, Pennsylvania (Newsfile Corp. - March 9, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced that Maria Maccecchini, Ph.D., Founder and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference. Annovis Bio s presentation will be available online beginning March 9, 2021 at 7:00 a.m. ET., and the presentation will be archived and available for replay for 90 days after the event.
The register and view the webcast, visit: https://journey.ct.events/view/f6675119-df47-4bf8-8553-6891b8fb3ee4
DBV Technologies S.A.: DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference
DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference
DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021.
A webcast of the presentation at the H.C. Wainwright Healthcare Conference will be available on the Investors & Media section of the Company s website beginning Tuesday, March 9
th at 7:00 a.m. ET:
ObsEva SA: ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference
Geneva, Switzerland and Boston, MA - March 3, 2021 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women s reproductive health, today announced that Company Management will provide a corporate update and participate in one-on-one investor meetings at the upcoming H.C. Wainwright Global Life Sciences Conference to be held March 9-10, 2021.
The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7 a.m. EST on Tuesday, March 9, 2021.
ObsEva webcast link [
here]
The presentation and archived webcast will also be accessible under Events Calendar in the investors section of ObsEva s [
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference
FRAMINGHAM, MA / ACCESSWIRE /
March 3, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ( Xenetic or the Company ), a biopharmaceutical company focused on advancing XCART, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.
In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website here.
Neovasc Inc.: Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - March 3, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 2021 H.C. Wainwright Global Life Sciences Conference that is scheduled to take place March 9-10, 2021. A recorded presentation by Bill Little, Neovasc s Chief Operating Officer, will be available on the Conference website starting at 7:00 am EST on March 9. Company management will also be scheduling one-on-one meetings with investors; meetings may be requested through H.C. Wainwright.
A link to the recorded presentation will also be available in the investor relations section of the Neovasc website at https://www.neovasc.com/investors/.